Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Neuronal Guidance Proteins as Diagnostic Markers for Acute Kidney Injury (AKI)

NCT05924269 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT05924269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05924269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Neuronal Guidance Proteins as Diagnostic Markers for Acute Kidney Injury (AKI)
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2023
Completion date
July 31, 2026
Enrollment
600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury